(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LEMONEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LEMONEX

ST13

US500000079323387

Class

35, 40, 42, 44

Filing

79323387

Registration

7361950

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

12/07/2024

Trademark type

Word

Nice classes

35, 40, 42, 44

Filing date

08/26/2021

Registration date

04/23/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/23/2024

Last transaction

04/23/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

01

Owner location

KR

Examiner

MASON, JARED MICHAEL

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

WON, Cheol Hee

Representatives

Jong Park The PL Law Group, PLLC

Technical classification

Nice Classes

Class 35Class 40Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Wholesale store services featuring diagnostic apparatus for medical use; sales agency servicesretail services by direct solicitation by sales agents featuring diagnostic apparatus for medical use; wholesale store services featuring diagnostic preparations for medical or veterinary purposes; wholesale store services featuring reagents for medical use; wholesale store services featuring cosmetics; wholesale store services featuring diagnostic reagents for pharmaceutical purposes; wholesale store services featuring synthetic peptides for pharmaceutical purposes; sales agency servicesretail services by direct solicitation by sales agents featuring for pharmaceuticals; wholesale store services featuring pharmaceutical preparations for diagnosis; sales agency servicesretail services by direct solicitation by sales agents featuring for medical apparatus and instruments; sales agency servicesretail services by direct solicitation by sales agents featuring for medicated mouth care and treatment preparations; sales agency servicesretail services by direct solicitation by sales agents featuring for masks for medical purposes; wholesale store services featuring chemical reagents for medical or veterinary purposes; wholesale store services featuring biological preparations for medical purposes; sales agency servicesretail services by direct solicitation by sales agents featuring for testing apparatus for medical purposes; sales agency servicesretail services by direct solicitation by sales agents featuring for balmsother than for medical purposes; sales agency servicesretail services by direct solicitation by sales agents featuring for non-medicated mouthwashes; sales agency servicesretail services by direct solicitation by sales agents featuring for aerosol dispensersnot for medical purposes

Class 40

Processing of chemical reagents; processing of pharmaceutical preparations; preservation of pharmaceuticals; custom manufacture of medical devices for others; custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of pharmaceuticals; processing of medicinal materials; processing of foodstuffs for use in manufacture

Class 42

Scientific research and development of amino acid for medical purpose; scientific research and development of peptide for medical purposes; scientific research for medical purposes; scientific development of cell therapy products; clinical studies of medicinesscientific research in the nature of conducting clinical trials of medicines for others; medical research; drug discovery services; pharmaceutical research and development; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; scientific cosmetics development services; DNA screening for scientific research purposes; research relating to biotechnology; biotechnology consulting services; scientific research and development of chemical amino acids; scientific research and development of DNA chips; scientific development of biologics; character designanimation design for others

Class 44

Preparation and dispensing of medications; provision of dietary food supplements for medical purposes being dispensing of medications; providing medical supplements for medical purposes being dispensing of medications; providing nutritional supplements for medical purposes being dispensing of medications; providing vitamin for medical purposes being dispensing of medications; medical and health services relating to DNAgenetics and genetic testingDNA and genetic testing for medical purposes; medical analysis for the diagnosis and treatment of persons; laboratory analysis services relating to the treatment of personsmedical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services relating to the removaltreatment and processing of human bloodumbilical cord bloodhuman cellsstem cells and bone marrow; medical analysis services for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; medical services in the field of oncology; medical services relating to the removaltreatment and processing of stem cells; medical testing services relating to the diagnosis and treatment of disease; medical care and analysis services relating to patient treatment; medical screening; medical services relating to the removaltreatment and processing of human cells; analysis of human tissues for medical treatment; analysis of human serum for medical treatment; provision of gene therapy for medical treatment purposes; provision of genetic information for medical treatment purposes; provision of genetic testing for medical treatment purposes; genetic testing of animals for diagnostic or treatment purposes

Publications

History of USPTO decisions and trademark events.

34 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/07/2024

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

10/22/2024

XXCR

GENERIC MADRID TRANSACTION CREATED

10/21/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/24/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/23/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/23/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/06/2024

PUBO

PUBLISHED FOR OPPOSITION

02/06/2024

GPNX

NOTIFICATION PROCESSED BY IB

02/05/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/17/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/17/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/17/2024

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

12/05/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/12/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/22/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

03/22/2023

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

08/09/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/25/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

07/25/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/25/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

07/25/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/25/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/20/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/20/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/20/2022

RFNP

REFUSAL PROCESSED BY IB

07/19/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/24/2022

RFRR

REFUSAL PROCESSED BY MPU

06/23/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/03/2022

CNRT

NON-FINAL ACTION WRITTEN

06/02/2022

DOCK

ASSIGNED TO EXAMINER

05/31/2022

MAFR

APPLICATION FILING RECEIPT MAILED

10/29/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/25/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/22/2021

Continuous trademark protection

Get notified about every new filing that threatens LEMONEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.